Not applicableStudy completedNCT02681237What this trial is testingCediranib and Olaparib at Disease Worsening in Ovarian CancerWho this might be right forOvarian Cancer University Health Network, Toronto 34
Early research (Phase 1)Study completedNCT02898207What this trial is testingOlaparib and Onalespib in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple-Negative Breast CancerWho this might be right forMetastatic High Grade Fallopian Tube Serous AdenocarcinomaMetastatic Malignant Solid NeoplasmMetastatic Primary Peritoneal Serous Adenocarcinoma+16 more National Cancer Institute (NCI) 28
Early research (Phase 1)Study completedNCT02210663What this trial is testingSingle Agent Veliparib in Japanese Subjects With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors AbbVie 16
Very early researchStudy completedNCT02316834What this trial is testingTalazoparib in Determining Genetic Effects on Disease Response in Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forFallopian Tube Serous AdenocarcinomaHigh Grade Ovarian Serous AdenocarcinomaOvarian Mass+16 more M.D. Anderson Cancer Center 4
Early research (Phase 1)Active Not RecruitingNCT02208375What this trial is testingMTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and OvarianWho this might be right forBRCA1 Mutation CarrierBRCA2 Mutation CarrierEndometrial Adenocarcinoma+13 more M.D. Anderson Cancer Center 159
Early research (Phase 1)Looking for participantsNCT06931626What this trial is testingStudy of NMS-03305293 in Adult Patient With Relapsed Small Cell Lung CancerWho this might be right forSmall Cell Lung Cancer Nerviano Medical Sciences 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05319249What this trial is testingNatural Killer Cell Immunotherapy in Combination With PARP-inhibition in Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia German Cancer Research Center 54
Early research (Phase 1)Looking for participantsNCT06545942What this trial is testingStudy of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid TumorsWho this might be right forAdvanced Solid TumorMetastatic Solid TumorProstate Cancer+4 more MOMA Therapeutics 220
Testing effectiveness (Phase 2)Study completedNCT03574779What this trial is testingEvaluate the Efficacy and Safety of Novel Treatment Combinations in Participants With Ovarian CancerWho this might be right forOvarian Neoplasms Tesaro, Inc. 77
Early research (Phase 1)Study completedNCT04179396What this trial is testingStudy of Oral Rucaparib With Other Anticancer Agents in Metastatic Castration Resistant Prostate Cancer Patients (RAMP)Who this might be right forMetastatic Castration Resistant Prostate Cancer pharmaand GmbH 8
Testing effectiveness (Phase 2)Study completedNCT03207347What this trial is testingA Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001)Who this might be right forMesotheliomaUveal MelanomaRenal Cell Carcinoma+1 more University of Florida 37
Testing effectiveness (Phase 2)Looking for participantsNCT06827717What this trial is testingPhase II Study of Irinotecan Liposome (II) Combined With Temozolomide and Fluzoparib in Recurrent or Metastatic Ewing SarcomaWho this might be right forEwing Sarcoma Sun Yat-sen University 29
Testing effectiveness (Phase 2)Looking for participantsNCT05990192What this trial is testingSBRT Alone or Followed by Niraparib for Oligometastases or Oligoprogression in Ovarian Cancer Following PARPi TherapyWho this might be right forOvarian Cancer Recurrent Institute of Cancer Research, United Kingdom 42
Early research (Phase 1)Study completedNCT03954366What this trial is testingDrug-Drug Interaction Study of Rucaparib, Rosuvastatin and Oral ContraceptivesWho this might be right forNeoplasms pharmaand GmbH 36
Testing effectiveness (Phase 2)Study completedNCT01472783What this trial is testingVeliparib Monotherapy for Relapsed Ovarian Cancer With BRCA MutationWho this might be right forRecurrent, Epithelial Ovarian Cancer Vejle Hospital 49
Post-approval studies (Phase 4)Looking for participantsNCT07695259What this trial is testingOlaparib+Trastuzumab+Pertuzumab Neoadjuvant for Elderly HER2+ Breast CancerWho this might be right forElderly FemalesHER2 + Breast CancerNeoadjuvant Therapy Wen-Ming Cao 45
Early research (Phase 1)WithdrawnNCT06719973What this trial is testingPhase 1 Study of M9466 Combined With Carboplatin and Platinum-based Anticancer Therapy (DDRiver 521)Who this might be right forAdvanced Solid Tumors EMD Serono Research & Development Institute, Inc.
Testing effectiveness (Phase 2)Active Not RecruitingNCT04728230What this trial is testingOlaparib and Durvalumab With Carboplatin, Etoposide, and/or Radiation Therapy for the Treatment of Extensive-Stage Small Cell Lung Cancer, PRIO TrialWho this might be right forExtensive Stage Lung Small Cell CarcinomaStage IV Lung Cancer AJCC v8Stage IVA Lung Cancer AJCC v8+1 more M.D. Anderson Cancer Center 63
Testing effectiveness (Phase 2)Study completedNCT03167619What this trial is testingPhase II Multicenter Study of Durvalumab and Olaparib in Platinum tReated Advanced Triple Negative Breast Cancer (DORA)Who this might be right forTriple Negative Breast Cancer Duke University 45
Testing effectiveness (Phase 2)Looking for participantsNCT04901702What this trial is testingStudy of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing SarcomaWho this might be right forRecurrent Solid TumorRecurrent Ewing SarcomaRecurrent Hepatoblastoma+19 more St. Jude Children's Research Hospital 90